Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors

Cancer Chemother Rep. 1974 Nov-Dec;58(6):943-5.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use*
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use*
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Fluorouracil / therapeutic use*
  • Humans
  • Male
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Neoplasms / drug therapy

Substances

  • Doxorubicin
  • Cyclophosphamide
  • Fluorouracil
  • Methotrexate